Coty vs P&G

8-K Financial Filing Analysis for Coty (2026-08-20)

On August 17, 2026, Coty Inc.'s Board of Directors approved a planned Chief Financial Officer transition. Laurent Mercier will step down as CFO effective August 31, 2026, without any disagreement with the company, and Soraya Benchikh will assume the role of CFO and principal financial officer effective September 1, 2026. Ms. Benchikh brings over twenty years of senior finance leadership, most recently serving as CFO of British American Tobacco. Her package includes an annual fixed salary of €1,165,000, target annual bonus of 150%, a €860,000 cash sign-on bonus, $2.5 million sign-on RSUs, 1.5 million stock options, and an annual $2.5 million long-term equity incentive. Additionally, the Board approved compensation increases for Executive Chairman and Interim CEO Markus Strobel—raising his base salary to $1,600,000 with a 170% target bonus and $3,000,000 annual equity grant—and a $1,275,000 retention bonus for Chief Legal Officer Kristin Blazewicz.

• Soraya Benchikh appointed as CFO effective September 1, 2026, succeeding Laurent Mercier whose departure is effective August 31, 2026.
• Benchikh receives €1.165 million base salary, 150% target bonus, €860,000 sign-on bonus, $2.5 million sign-on RSUs, 1.5 million stock options, and $2.5 million annual target LTI.
• Interim CEO Markus Strobel's base salary increased to $1.6 million (from $1.25 million) with a 170% bonus target and $3.0 million annual equity grant; CLO Kristin Blazewicz granted a $1.275 million retention bonus.

8-K Financial Filing Analysis for Coty (2026-09-11)

Coty Inc. reported formal leadership transition terms for outgoing Chief Financial Officer Laurent Mercier following the appointment of Soraya Benchikh as CFO. Mercier stepped down as CFO on September 1, 2026, transitioning to a Strategic CEO Advisor role through June 30, 2027. Under the Transition Agreement, Mercier will maintain an annual base salary of €825,000, actively assisting with handoff duties through October 2026 before being released from active responsibilities on November 1, 2026. The agreement specifies an optional early exit acceleration starting December 20, 2026, a fixed one-time bonus of €290,000 in lieu of standard FY2026/FY2027 variable compensation, continued vesting of October 2026 equity tranches, and standard post-employment non-compete terms.

• Laurent Mercier stepped down as CFO on September 1, 2026, serving as Strategic CEO Advisor through June 30, 2027, with full duties ending October 31, 2026.
• Mercier will continue to receive an annual base salary of €825,000 and a one-time fixed bonus of €290,000, while forfeiting variable bonuses for FY2026 and FY2027.
• The Transition End Date can be accelerated at Mercier's option to no earlier than December 20, 2026, with equity scheduled to vest in October 2026 remaining eligible to vest.

Coty Strengthens U.S. Consumer Beauty Leadership with Key Appointments

Coty Inc. announced the appointment of Kara Langan as General Manager, Consumer Beauty U.S., marking a significant step in strengthening the company's Consumer Beauty leadership team and accelerating growth in one of its most important markets.

8-K Financial Filing Analysis for P&G (2026-10-30)

On October 30, 2026, The Procter & Gamble Company closed a multi-tranche underwritten public debt offering totaling $4.0 billion in aggregate principal amount under its Form S-3 shelf registration. The issuance comprises four tranches: $750 million of 5.125% Notes due 2031, $750 million of 5.300% Notes due 2033, $1.25 billion of 5.450% Notes due 2036, and $1.25 billion of 5.900% Notes due 2056. The large-scale capital raise locks in medium- and long-term liquidity across 5-year, 7-year, 10-year, and 30-year maturities. This debt financing provides P&G with substantial balance sheet flexibility to support general corporate purposes, debt refinancing, and operational capital allocation requirements.

• P&G closed an underwritten public offering of $4.0 billion in total aggregate principal across four tranches on October 30, 2026.
• The offering includes $750M of 5.125% Notes due 2031, $750M of 5.300% Notes due 2033, $1.25B of 5.450% Notes due 2036, and $1.25B of 5.900% Notes due 2056.
• The debt was issued under P&G's Form S-3 registration statement (Registration No. 333-299472) with legal opinions filed by internal counsel and Fried, Frank, Harris, Shriver & Jacobson LLP.

10-Q Financial Filing Analysis for P&G (2026-10-22)

For the first fiscal quarter ended September 30, 2026, The Procter & Gamble Company reported consolidated net sales of $23.28 billion, up 4.0% year-over-year, driven by a 2.4% unit volume increase, 1.1% positive geographic mix, and 0.4% higher pricing. Operating income rose 1.4% to $5.94 billion, while gross margin contracted 160 basis points to 49.8% due to higher commodity costs and product/packaging investments, partially offset by manufacturing productivity gains. Net earnings attributable to P&G declined marginally to $4.73 billion, while diluted EPS increased 1% to $1.97 (Core EPS rose 1% to $2.00). Operating cash flow reached $5.77 billion with free cash flow of $4.40 billion, demonstrating solid 93% free cash flow productivity. Subsequent to quarter-end on October 1, 2026, P&G completed the $3.9 billion all-cash acquisition of premium wellness brand Thorne. The company also progressed its two-year $2.0 billion portfolio and productivity restructuring plan, which aims to reduce up to 7,000 non-manufacturing personnel by the end of fiscal 2027.

• Net sales rose 4.0% year-over-year to $23.28 billion, supported by 2.4% volume growth and 4.0% organic sales growth.
• Gross margin compressed by 160 basis points to 49.8%, impacted by commodity headwinds and packaging investments, though buffered by SG&A leverage to deliver $5.94 billion in operating income.
• Closed the $3.9 billion all-cash acquisition of wellness supplement maker Thorne on October 1, 2026, integrating it into Personal Health Care.

8-K Financial Filing Analysis for P&G (2026-10-16)

The Procter & Gamble Company filed a Form 8-K reporting the final voting results from its Annual Meeting of Shareholders held on October 13, 2026. Shareholders approved all management-sponsored proposals, including the election of 12 directors for one-year terms, the ratification of the independent registered public accounting firm, and the advisory approval of executive compensation ('Say on Pay'). Conversely, all three shareholder-sponsored proposals—addressing lower thresholds for special meetings, eligibility thresholds for shareholder proposal proponents, and annual reporting on charitable contributions—were defeated by substantial margins.

• All 12 director nominees, including Ashley McEvoy (1.64B votes for) and Joseph Jimenez (1.56B votes for), were elected to one-year terms on the Board.
• Executive compensation ('Say on Pay') was approved with 1,514,086,600 votes in favor, 138,017,439 against, and 13,038,485 abstentions.
• Three shareholder proposals were rejected, including a measure to lower the special meeting threshold (608.5M votes for vs. 1.04B against) and a charitable contribution disclosure proposal (defeated with 1.57B votes against).